Succeeding in today’s complex pharmaceutical business environment requires a new supply network model based on transparency and collaboration with supply and trade partners
Woburn, MA (PRWEB) November 30, 2011
TraceLink, Inc., developer of the TraceLink Network, the world’s first industry-wide supply collaboration network, today announced that the company’s President and CEO Shabbir Dahod will lead an interactive session on ensuring supply, capacity and quality in today’s virtual Life Sciences supply network at the Pharma SC&L Conference in Myrtle Beach, SC on Dec. 6-7. Mr. Dahod will host a think tank discussion on how pharma/biopharma leaders can improve production KPIs and address critical business issues such as drug shortages through an integrated, collaborative business network.
Mr. Dahod’s session, entitled “Ensuring Supply, Capacity and Quality in the Virtual Pharmaceutical Supply Chain”, will challenge attendees to think critically by combining real-world examples with recent research on supply network collaboration to explore:
- How drug shortages, product recalls, pharmerging market demand and other business issues impact supply chain planning and execution
- The complexity of the commercial and clinical outsourced production environment in Life Sciences
- Business, operational and information challenges created as production is outsourced
- The collaborative business network architecture required to ensure visibility, accountability and control across external supply relationships
- Needs of the CMO and CPO in the pharmaceutical contract manufacturing relationship
- Opportunities to drive joint business value in a collaborative supply network
“As a company moves towards a virtual execution model, it challenges supply chain, IT and quality leaders with how to tightly monitor, measure and manage a supply network made up of diverse business relationships, production processes, information flows and users,” said Dahod. “Succeeding in today’s complex supply environment requires a new operating model based on transparency and collaboration with supply and trade partners. I look forward to leading a vibrant discussion on this important topic at one of the leading events bringing together life science business leaders.”
To learn more about TraceLink’s cloud-based solutions for integrating the supply network, improving production visibility, reducing time and risk in the pharmaceutical quality review process and ensuring pharmaceutical serialization and traceability compliance, visit http://www.tracelink.com.
TraceLink helps companies and business leaders across the Life Sciences supply chain connect and collaborate to improve manufacturing and supply chain performance through the TraceLink Network. The TraceLink Network is a Cloud-based platform that prevents counterfeits, detects diversion, minimizes inventory, reduces cycle-time and ensures on-time delivery for all members of the supply chain by integrating its participants into a network of interoperable, collaborative business processes shared across companies. Pharmaceutical / biopharmaceutical companies, CMOs/CPOs and their supply chain partners quickly forge high-value partnerships by connecting with an “integrate-once, interoperate with everyone” transaction platform, an integrated set of shared business modules and a collaborative team workspace based on social networking principles that puts key and actionable supply network data into the hands of business owners.
TraceLink is funded by FirstMark Capital, a venture capital firm managing more than $2 billion in capital commitments. For more information on TraceLink and our solutions, visit http://www.tracelink.com.